Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008

NCT00421707 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00421707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00421707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
October 14, 2006
Completion date
June 25, 2008
Enrollment
133 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome (ibs)